Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice.

about

Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.

P2860

Q52805260-DA675F6C-4C47-4794-AB52-7E18C4757276

P2860

Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice.

Item

http://www.wikidata.org/entity/Q40409105

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Continuation of low-molecular- ...... dy in daily clinical practice.

@en

type

Item

label

Continuation of low-molecular- ...... dy in daily clinical practice.

@en

prefLabel

Continuation of low-molecular- ...... dy in daily clinical practice.

@en

P1476

Continuation of low-molecular- ...... udy in daily clinical practice

@en

P2093

D Barrios

http://www.w3.org/2001/XMLSchema#string

D Jimenez

http://www.w3.org/2001/XMLSchema#string

M V Huisman

http://www.w3.org/2001/XMLSchema#string

P L den Exter

http://www.w3.org/2001/XMLSchema#string

R Morillo

http://www.w3.org/2001/XMLSchema#string

S J van der Wall

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants.

Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism.

Venous thromboembolism and cancer: risks and outcomes.

Diagnostic management of acute deep vein thrombosis and pulmonary embolism.

Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.

Treatment of venous thromboembolism in ambulatory cancer patients in Germany: a prospective non-interventional study.

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study.

Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period.

P304

74-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JTH.13563

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Suzanne C. Cannegieter

Frederikus A Klok

P577

2016-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28012224

http://www.w3.org/2001/XMLSchema#string

Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice.

about

P2860

P2860

Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698